pubmed-article:1343613 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:1343613 | lifeskim:mentions | umls-concept:C0025663 | lld:lifeskim |
pubmed-article:1343613 | lifeskim:mentions | umls-concept:C0004153 | lld:lifeskim |
pubmed-article:1343613 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:1343613 | lifeskim:mentions | umls-concept:C1417035 | lld:lifeskim |
pubmed-article:1343613 | lifeskim:mentions | umls-concept:C0684321 | lld:lifeskim |
pubmed-article:1343613 | lifeskim:mentions | umls-concept:C1442488 | lld:lifeskim |
pubmed-article:1343613 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:1343613 | lifeskim:mentions | umls-concept:C0242747 | lld:lifeskim |
pubmed-article:1343613 | lifeskim:mentions | umls-concept:C1707689 | lld:lifeskim |
pubmed-article:1343613 | pubmed:dateCreated | 1994-3-17 | lld:pubmed |
pubmed-article:1343613 | pubmed:abstractText | The Monitored Atherosclerosis Regression Study (MARS) was designed to evaluate the effect of cholesterol lowering by monotherapy with an HMG-CoA reductase inhibitor on progression/regression of atherosclerosis in subjects with angiographically documented coronary artery disease. The purpose of this paper is to present the design, methods, and baseline results of MARS. | lld:pubmed |
pubmed-article:1343613 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1343613 | pubmed:language | eng | lld:pubmed |
pubmed-article:1343613 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1343613 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:1343613 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1343613 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1343613 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1343613 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1343613 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1343613 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1343613 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:1343613 | pubmed:month | Oct | lld:pubmed |
pubmed-article:1343613 | pubmed:issn | 1059-2725 | lld:pubmed |
pubmed-article:1343613 | pubmed:author | pubmed-author:HirschL JLJ | lld:pubmed |
pubmed-article:1343613 | pubmed:author | pubmed-author:AzenS PSP | lld:pubmed |
pubmed-article:1343613 | pubmed:author | pubmed-author:KramschD MDM | lld:pubmed |
pubmed-article:1343613 | pubmed:author | pubmed-author:HwangII | lld:pubmed |
pubmed-article:1343613 | pubmed:author | pubmed-author:DeBoerLL | lld:pubmed |
pubmed-article:1343613 | pubmed:author | pubmed-author:LoboF GFG | lld:pubmed |
pubmed-article:1343613 | pubmed:author | pubmed-author:DeMetsDD | lld:pubmed |
pubmed-article:1343613 | pubmed:author | pubmed-author:DeBoerL WLW | lld:pubmed |
pubmed-article:1343613 | pubmed:author | pubmed-author:Cashin-Hemphi... | lld:pubmed |
pubmed-article:1343613 | pubmed:author | pubmed-author:VailasLL | lld:pubmed |
pubmed-article:1343613 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:1343613 | pubmed:day | 23 | lld:pubmed |
pubmed-article:1343613 | pubmed:volume | Doc No 26 | lld:pubmed |
pubmed-article:1343613 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:1343613 | pubmed:authorsComplete | N | lld:pubmed |
pubmed-article:1343613 | pubmed:pagination | [9897 words; 83 paragraphs] | lld:pubmed |
pubmed-article:1343613 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:1343613 | pubmed:meshHeading | pubmed-meshheading:1343613-... | lld:pubmed |
pubmed-article:1343613 | pubmed:meshHeading | pubmed-meshheading:1343613-... | lld:pubmed |
pubmed-article:1343613 | pubmed:meshHeading | pubmed-meshheading:1343613-... | lld:pubmed |
pubmed-article:1343613 | pubmed:meshHeading | pubmed-meshheading:1343613-... | lld:pubmed |
pubmed-article:1343613 | pubmed:meshHeading | pubmed-meshheading:1343613-... | lld:pubmed |
pubmed-article:1343613 | pubmed:meshHeading | pubmed-meshheading:1343613-... | lld:pubmed |
pubmed-article:1343613 | pubmed:meshHeading | pubmed-meshheading:1343613-... | lld:pubmed |
pubmed-article:1343613 | pubmed:meshHeading | pubmed-meshheading:1343613-... | lld:pubmed |
pubmed-article:1343613 | pubmed:meshHeading | pubmed-meshheading:1343613-... | lld:pubmed |
pubmed-article:1343613 | pubmed:meshHeading | pubmed-meshheading:1343613-... | lld:pubmed |
pubmed-article:1343613 | pubmed:meshHeading | pubmed-meshheading:1343613-... | lld:pubmed |
pubmed-article:1343613 | pubmed:meshHeading | pubmed-meshheading:1343613-... | lld:pubmed |
pubmed-article:1343613 | pubmed:meshHeading | pubmed-meshheading:1343613-... | lld:pubmed |
pubmed-article:1343613 | pubmed:meshHeading | pubmed-meshheading:1343613-... | lld:pubmed |
pubmed-article:1343613 | pubmed:meshHeading | pubmed-meshheading:1343613-... | lld:pubmed |
pubmed-article:1343613 | pubmed:meshHeading | pubmed-meshheading:1343613-... | lld:pubmed |
pubmed-article:1343613 | pubmed:meshHeading | pubmed-meshheading:1343613-... | lld:pubmed |
pubmed-article:1343613 | pubmed:meshHeading | pubmed-meshheading:1343613-... | lld:pubmed |
pubmed-article:1343613 | pubmed:year | 1992 | lld:pubmed |
pubmed-article:1343613 | pubmed:articleTitle | The Monitored Atherosclerosis Regression Study (MARS). Design, methods and baseline results. | lld:pubmed |
pubmed-article:1343613 | pubmed:affiliation | Atherosclerosis Research Institute, University of Southern California School of Medicine, Los Angeles 90033. | lld:pubmed |
pubmed-article:1343613 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:1343613 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:1343613 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:1343613 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |